Skip to main content
See every side of every news story
Published loading...Updated

Screening for Breast Cancer

Summary
To the Editor The prevailing one-size-fits-all paradigm of breast cancer screening—largely based on age and fixed intervals—was designed during an era with limited risk stratification, few prevention pathways, and limited ability to tailor imaging intensity. Pragmatic randomized clinical trials, such as WISDOM, are therefore essential to generate evidence with a prevention strategy that can reallocate resources from women at lower risk of breast…

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

JAMA Network broke the news on Tuesday, May 12, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal